Загрузка...
Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology
Induced pluripotent stem cell (iPSC) technology is increasingly being used to create in vitro models of monogenic human disorders. This is possible because, by and large, the phenotypic consequences of such genetic variants are often confined to a specific and known cell type, and the genetic varian...
Сохранить в:
| Опубликовано в: : | Front Endocrinol (Lausanne) |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047192/ https://ncbi.nlm.nih.gov/pubmed/33868170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.635662 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|